Pharma & Life Sciences Global (1001+ employees)

Medical Director at Global

High Openness and Extraversion to lead medical-scientific strategy, represent the company before agencies, and build clinical positioning.

Global pharma means registrations in dozens of markets with different requirements

Multi-site clinical trials are extreme international coordination projects

Pricing and access pressures vary drastically between countries

Ideal OCEAN+ Profile

Openness 77 Conscientiousness 87 Extraversion 73 Agreeableness 80 Emotional Stability 70 Structure & Rhythm 82
Ideal range
Openness
70 84

At global corporations (1001+ employees), strategic scientific vision to design the evidence plan, lead advisory boards, and anticipate the medical landscape that will impact the portfolio

Conscientiousness
80 94

At global corporations (1001+ employees), rigor in validating shared medical information, compliance with reporting obligations, and quality of the evidence strategy

Extraversion
66 80

At global corporations (1001+ employees), executive presence in the C-suite, leadership of medical teams, and representation of the company before KOLs, agencies, and academia

Agreeableness
73 87

At global corporations (1001+ employees), cross-functional influence over commercial, regulatory, and access teams to align medical strategy with business needs

Emotional Stability
63 77

At global corporations (1001+ employees), handling safety crises, public scientific controversies, and business performance pressure that demand difficult medical-ethical decisions

Structure & Rhythm
73 90

At global corporations (1001+ employees), the Medical Director alternates between medical process governance and scientific exploration; needs comfort with regulatory frameworks without structure preventing adjustments to the evidence plan when the clinical landscape shifts

Strengths and Red Flags

Strengths

  • Design of clinical evidence strategy that positions the portfolio in treatment guidelines
  • Scientific representation of the company before KOLs, agencies, and public health bodies
  • Registering and commercializing pharmaceutical products across multiple regulatory markets
  • Managing multi-site, multi-country clinical trials under ICH-GCP standards

Red Flags

  • Subordinating scientific objectivity to commercial business pressures
  • Disconnection from the real clinical environment, generating medical strategies that physicians do not adopt
  • Underestimates the variability of regulatory requirements across markets
  • Centralized registration management that ignores local particularities

Interview Questions

Describe the most complex evidence strategy you designed. How did you balance scientific needs with the business's timelines and resources?

Evaluates: Strategic Openness and ability to balance science with business

The commercial team wants to position a subgroup finding that is statistically significant but clinically questionable. What position do you take and how do you communicate it internally?

Evaluates: Conscientiousness and medical-scientific integrity under commercial pressure

How did you manage a multi-site, multi-country clinical trial?

Evaluates: International coordination and multi-regulatory compliance

How did you navigate pricing and access differences between markets?

Evaluates: Strategic thinking and sensitivity to local health dynamics

More about Medical Director

Career path, personality archetypes and similar roles in the full profile.

This Role in Other Contexts

You're hiring a Medical Director at Global (1001+ employees). Is your company ready?

This profile describes who to look for. The Talent Diagnostic measures the other half: how ready your organization is for that person to perform. Free, no signup.

20 statements · 5 min · no card